Home
Keryx Biopharmaceuticals Inc

Keryx Biopharmaceuticals... Market Share Analysis for November 2025

Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.

Health > Biotechnology and Pharmaceuticals

Domainkeryx.com

Year Founded1998

Employees51 - 200

Annual Revenue$75M - $100M

Keryx Biopharmaceuticals Inc

Keryx Biopharmaceuticals Inc (including company regionals)

keryx.com

See more website traffic and engagement information

Keryx Biopharmaceuticals Inc Revenue up to November 2025 is 75M - 100M

revenue generated by Keryx Biopharmaceuticals Inc top domains

Keryx Biopharmaceuticals Inc top domains revenue over 3 years

Revenue for Keryx Biopharmaceuticals Inc top domains

keryx.com75M - 100M

See more with Sales Intelligence

Total visits to Keryx Biopharmaceuticals Inc's top domains

Understand Keryx Biopharmaceuticals Inc market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Keryx Biopharmaceuticals Inc's top domains

Analyze Keryx Biopharmaceuticals Inc engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Keryx Biopharmaceuticals Inc's top domains

See how Keryx Biopharmaceuticals Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Keryx Biopharmaceuticals Inc top competitors by domain

Top similar sites in November 2025, ranked by their affinity

immunogen.comCompany NameImmunoGenEmployees501 - 1000HQUnited States, Massachusetts, WalthamAnnual revenue$200M - $500MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Keryx Biopharmaceuticals Inc

These are the website technologies, by industry, used by Keryx Biopharmaceuticals Inc top domains

Social (4)

Instagram

Widget (4)

Twemoji

Conversion & Analytics (2)

Google Analytics

Email Services (2)

G Suite

More Technologies

8

See all

News & Signals from Keryx Biopharmaceuticals Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAkebia Therapeutics, Inc. acquired Keryx Biopharmaceuticals, Inc. on Jan 1st '18.And in 2018, Akebia acquired Keryx Biopharmaceuticals, which had already been partnering with the NKF for a long time.

NewsKeryx Biopharmaceuticals, Inc. is developing Zerenex.Keryx is developing Zerenex™, an iron-based phosphate binder for the treatment of elevated serum phosphorus levels (hyperphosphatemia) in patients with ESRD.

NewsKeryx Biopharmaceuticals, Inc. launched U.S. FDA approval of drug for iron deficiency anemia Auryxia on Nov 1st '17.In November 2017, Keryx Biopharmaceuticals, Inc (U.S.) announced the U.S. FDA approval of drug for iron deficiency anemia Auryxia, used in the treatment of ron deficiency anemia in adults with chronic kidney disease (CKD) not suitable for patient on dialysis.